Shareholders who lost money in shares of agilon health, inc. (NYSE: AGL) Should Contact Wolf Haldenstein Immediately

Core Viewpoint - A federal securities class action has been filed against Agilon Health, Inc. for alleged securities fraud during the class period from February 6, 2025, to August 4, 2025, with a deadline for investors to seek lead plaintiff status by March 2, 2026 [1][2]. Group 1: Legal Action - The complaint alleges that Agilon and certain officers and/or directors engaged in securities fraud or other unlawful business practices [2]. - Investors who purchased Agilon shares during the specified class period are eligible to join the class action [1]. Group 2: Market Reaction - Following the announcements made on August 4, 2025, Agilon's stock price fell by $0.94 per share, representing a 51.52% decline, closing at $0.88 on August 5, 2025 [3]. Group 3: Company Leadership and Financial Update - Steven Sell has stepped down as President, CEO, and Board Director of Agilon [7]. - The company reported its Q2 2025 results, with the Executive Chair noting that industry headwinds were "more acute than previously expected" [7]. - Agilon has suspended its full-year 2025 financial guidance due to these challenges [7].